Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
One World ProductsOWPC 5-Year Yield-on-Cost % is 0.00 as of Jul. 29, 2026. The stock has 4 warning signs investors should review. Among 514 Drug Manufacturers companies, One World Products ranks worse than 194552.33% on this metric.
One World Products's yield on cost for the quarter that ended in Sep. 2025 was 0.00.
The historical rank and industry rank for One World Products's 5-Year Yield-on-Cost % or its related term are showing as below:
OWPC's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.305 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
One World Products (OTCPK:OWPC) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
One World Products 5-Year Yield-on-Cost % Related Terms
OWPC vs CBSTQ, PTPI, KOAN: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, One World Products's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
One World Products 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, One World Products's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where One World Products's 5-Year Yield-on-Cost % falls into.
One World Products 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
One World Products (OWPC) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 29, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on One World Products and its competitors. According to the industry distribution chart, One World Products ranks #999999 out of 514 companies in the Drug Manufacturers industry.
Is One World Products' 5-Year Yield-on-Cost % too high?
One World Products' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, One World Products ranks #999999 out of 514 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does One World Products' 5-Year Yield-on-Cost % compare to CBSTQ and PTPI?
According to the Drug Manufacturers industry distribution chart, One World Products ranks #999999 out of 514 companies for 5-Year Yield-on-Cost %. This places One World Products in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.31, based on 514 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on One World Products and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. One World Products's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is One World Products stock overvalued right now?
One World Products (OWPC) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For One World Products (OWPC), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
One World Products Inc along with its subsidiaries is engaged in the cultivation, production, and distribution of raw cannabis and hemp plant ingredients for both medical and industrial uses. It focuses on cultivating, processing, and supplying cannabis oil, distillate, and isolate to customer's specifications. The Company operates as a single segment, consisting of its CBD sales operations in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OWPC has been successfully added to your 
